These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3155580)

  • 1. Further phenotypic characterization of T cells after human allogeneic bone marrow transplantation.
    Elfenbein GJ; Ashkenazi YJ; Barth KC
    Transplantation; 1985 Jan; 39(1):97-102. PubMed ID: 3155580
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring of T-lymphocyte regeneration following allogeneic bone marrow transplantation using monoclonal antibodies.
    Gratama JW; Bolhuis RL
    Neth J Med; 1985; 28(3):128-33. PubMed ID: 3157071
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometric analysis of T lymphocyte subsets after human bone marrow transplantation using monoclonal antibodies and dual immunofluorescence].
    Matsue K; Yasue S; Iwabuchi K; Ohtsuka M; Ueda M; Kondo K; Shiobara S; Mori T; Matsuda T; Harada M
    Nihon Ketsueki Gakkai Zasshi; 1989 May; 52(3):659-64. PubMed ID: 2694718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-lymphocyte subpopulations identified by monoclonal antibodies after human bone-marrow transplantation.
    Tubiana N; Maraninchi D; Mawas C; Lecaer F; Sainty D; Sebahoun G; Olive D; Gastaut JA; Carcassonne Y
    Pathol Biol (Paris); 1985 Mar; 33(3):173-8. PubMed ID: 3892443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regeneration of lymphocyte subpopulations after bone marrow transplantation: a study with monoclonal antibodies of the BL-series.
    Pönisch W; Leiblein S; Friedrich T; Schwenke H; Helbig W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):527-30. PubMed ID: 2480302
    [No Abstract]   [Full Text] [Related]  

  • 8. T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies.
    de Bruin HG; Astaldi A; Leupers T; van de Griend RJ; Dooren LJ; Schellekens PT; Tanke HJ; Roos M; Vossen JM
    J Immunol; 1981 Jul; 127(1):244-51. PubMed ID: 6787124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients.
    Andersen CB; Horn T; Sehested M; Junge J; Jacobsen N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1250-4. PubMed ID: 8442105
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
    Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
    Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
    Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
    Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
    [No Abstract]   [Full Text] [Related]  

  • 13. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody].
    Irlé C; Kaestli M; Chapuis B; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1517-8. PubMed ID: 3909385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation.
    Prentice HG
    J Clin Immunol; 1982 Jul; 2(3 Suppl):148S-153S. PubMed ID: 6290527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human regulatory T-cell subsets.
    Young M; Geha RS
    Annu Rev Med; 1986; 37():165-72. PubMed ID: 2939789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation.
    de Vries E; van Tol MJ; van den Bergh RL; Waaijer JL; ten Dam MM; Hermans J; Vossen JM
    Bone Marrow Transplant; 2000 Feb; 25(3):267-75. PubMed ID: 10673698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total lymphoid irradiation in kidney and liver transplantation in the baboon: prolonged graft survival and alterations in T cell subsets with low cumulative dose regimens.
    Myburgh JA; Smit JA; Stark JH; Browde S
    J Immunol; 1984 Feb; 132(2):1019-25. PubMed ID: 6228586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell phenotypic profile and colony formation during recovery from cytotoxic therapy-induced marrow aplasia.
    Ashkenazi YJ; Barth KC; Elfenbein GJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6513-8. PubMed ID: 3933827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.